Pulse Biosciences, Inc. financial data

Symbol
PLSE on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
3957 Point Eden Way, Hayward, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Electroblate, Inc. (to 11/13/2014)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 945 % +10.3%
Debt-to-equity 22.5 % -73.4%
Return On Equity -83.3 % +27.8%
Return On Assets -68 % -8.81%
Operating Margin 442K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 67.3M shares +21.8%
Common Stock, Shares, Outstanding 65.9M shares +19.6%
Entity Public Float 183M USD +47.5%
Common Stock, Value, Issued 66K USD +20%
Weighted Average Number of Shares Outstanding, Basic 58.4M shares +17.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Cost of Revenue 0 USD -100%
Research and Development Expense 32.3M USD +16.3%
General and Administrative Expense 23.9M USD +51.6%
Costs and Expenses 56.3M USD +29.1%
Operating Income (Loss) -56.3M USD -29.1%
Nonoperating Income (Expense) 2.67M USD +95.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -53.6M USD -26.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -53.6M USD -26.9%
Earnings Per Share, Basic -0.92 USD/shares -8.24%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 118M USD +166%
Assets, Current 119M USD +164%
Property, Plant and Equipment, Net 1.16M USD -24.1%
Operating Lease, Right-of-Use Asset 7.16M USD -1.28%
Goodwill 2.79M USD 0%
Other Assets, Noncurrent 677K USD +85.5%
Assets 132M USD +124%
Accounts Payable, Current 1.67M USD -8.88%
Employee-related Liabilities, Current 4.1M USD +28.1%
Accrued Liabilities, Current 7.03M USD +84.2%
Contract with Customer, Liability, Current 4K USD -75%
Liabilities, Current 10.1M USD +49.9%
Operating Lease, Liability, Noncurrent 7.54M USD -6.72%
Liabilities 17.6M USD +19%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -391M USD -15.9%
Stockholders' Equity Attributable to Parent 115M USD +159%
Liabilities and Equity 132M USD +124%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.78M USD -48.9%
Net Cash Provided by (Used in) Financing Activities 305K USD
Net Cash Provided by (Used in) Investing Activities -39K USD +86%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 65.9M shares +19.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.48M USD -34.6%
Deferred Tax Assets, Valuation Allowance 99.5M USD +13.3%
Deferred Tax Assets, Gross 101M USD +13%
Operating Lease, Liability 8.9M USD -2.69%
Depreciation 512K USD -5.54%
Payments to Acquire Property, Plant, and Equipment 5K USD -87.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -53.6M USD -26.9%
Lessee, Operating Lease, Liability, to be Paid 11.2M USD -7.52%
Property, Plant and Equipment, Gross 5.13M USD +2.48%
Operating Lease, Liability, Current 1.36M USD +28.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.23M USD +12.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.15M USD +12.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.31M USD -22.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.3M USD +12.5%
Deferred Tax Assets, Operating Loss Carryforwards 67M USD +9.63%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 17.4M USD +70.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.38M USD +12.5%
Operating Lease, Payments 469K USD +3.53%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 167K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 1.6M USD -3.33%
Share-based Payment Arrangement, Expense 13.6M USD +89.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%